Across primary care practices, guideline adherence remains suboptimal for chlamydia and gonorrhea, according to a study ...

Across primary care practices, guideline adherence remains suboptimal for chlamydia and gonorrhea, according to a study ...

Higher treatment rates were seen for females, individuals aged 10 to 29 years, suburban dwellers, and patients with chlamydia-gonorrhea coinfection. HealthDay News — Across primary care ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer ...

As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety of its novel mRNA vaccine in preventing chlamydia.

Universal opt-out programs raise sexually transmitted infection screening rates in adolescents, though confidentiality issues may affect commercially insured patients.

Visby Medical’s at-home diagnostic, which can be purchased without a prescription, tests for chlamydia, gonorrhea and ...

The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...